Hepatocellular Carcinoma
Patients with untreated hepatocellular carcinoma face grim outcomes despite supportive treatment
Published in Drug Week, November 11th, 2005
According to a study from the People's Republic of China, "HCC is common in Asia, and the majority are not suitable for curative surgical treatment. We studied the natural history of untreated nonsurgical HCC to examine whether the prognosis has changed with improved supportive treatment and to identify factors affecting survival."
"One hundred and six ethnic Chinese patients with HCC not amenable to curative treatment were managed symptomatically as control-arm patients in 3 randomized studies conducted between January 1996 and April 2001....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-11-11)
More Articles from Drug Week
- Breast Cancer
Curcumin halts spread of breast cancer in mice - Cancer Therapy
Median survival improved by more than half in phase III metastatic melanoma trial of Oncophage - Drug Development
Phase II trial initiated for Cand5 in wet age-related macular degeneration - Renal Cell Carcinoma
Preliminary data shows renal cancer drug is safe and well tolerated - Systemic Lupus Erythematosus
LymphoStat-B shown to be safe, well-tolerated in patients with systemic lupus erythematosus - Addiction Medicine
Beta-carbolines block opiate withdrawal - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
